THE PBM PARTNER EMPLOYERS DESERVE

Learn More About Us
shutterstock_1378541096
https://www.epiphanyrx.com/wp-content/uploads/2023/01/shutterstock_13785410965-scaled.jpg

The Pharmacy Benefit Manager Employers Deserve

 

https://www.epiphanyrx.com/wp-content/uploads/2023/01/7.png

Discover a better way to manage pharmacy benefits

https://www.epiphanyrx.com/wp-content/uploads/2023/01/14.png

Discover a better way to manage pharmacy benefits

4

CONTACT US

16

SOLUTIONS

13

NEWS & INSIGHTS

10-1

ABOUT US

CONTACT-US

RESOURCES

shutterstock_795100945

ABOUT US

https://www.epiphanyrx.com/wp-content/uploads/2022/12/shutterstock_586587755-1-scaled.jpg

Discover a better way to manage pharmacy benefits

shutterstock_1199457382-2

WE BELIEVE

PBMs should make 100% of their revenue from fees paid directly by their clients. This alignment of financial interests is essential to managing costs.

Coverage should be based on lowest net cost and value, not on rebate maximization or optimizing the profits of the PBM-owned pharmacy.

Full visibility of performance metrics is a critical foundation to holding the PBM accountable.

 

We Believe

PBMs should make 100% of their revenue from fees paid directly by their clients. This alignment of financial interests is essential to managing costs.

Coverage should be based on lowest net cost and value, not on rebate maximization or optimizing the profits of the PBM-owned pharmacy.

Full visibility of performance metrics is a critical foundation to holding the PBM accountable.

 

mom holding son

WE'RE NOT FOR EVERYONE

Just those who want more from their pharmacy benefits.

Fully aligned, value-based, transparent benefits are possible – for PBMs willing to use them, and for employers that insist on them.

Discover how EpiphanyRx is providing significant, ongoing savings for our clients in a way that no one else does.

EXPLORE MORE
man with arms crossed in lab coat and glasses

WE'RE BREAKING THE TRADITIONAL PBM MOLD

We are removing the conflicts of interest that limit traditional PBMs.

We replace spread pricing, rebate retention and pharmacy ownership with an aligned, transparent business model focused on the lowest net cost and overall value for our clients.

EXPLORE MORE
running a race
Alignment
female pharmacist smiling
Transparency
Real Savings
team meeting
Value-Based Coverage
hugging group

News & Insights

The Fast Five: Let’s Be Clear. What Does Transparency Mean in PBM Pricing?

While some pharmacy benefit managers (PBMs) have been talking about transparency for years, it has become an increasingly hot topic in the health care industry. So what does transparency really mean? Let’s take a fast five (minutes) to look at PBM pricing models and how transparency comes into play.

The Fast Five: Let’s Be Clear. What Does Transparency Mean in PBM Pricing?
The Fast Five: Drug Pricing Disruptors

Everyone is hearing a lot about prescription drug pricing lately thanks to a very famous billionaire entrepreneur. What is cost-plus pricing? Is it new? How is it disrupting the industry? In this Fast Five, we share answers to these questions and provide guidance on how to evaluate this model. For a smart insider’s perspective, we consulted with Sharon Faust, Senior Vice President, Lumicera Specialty Pharmacy. 

The Fast Five: Drug Pricing Disruptors
The Fast Five: Time to Move On? How the Right PBM Will Guide Your Implementation Process

Making a pharmacy benefit manager (PBM) transition can be a daunting task especially for busy benefit teams. We consulted our internal implementation experts on what a smooth transition looks like and how the right partner will provide reassurance that you are making the right move. 

The Fast Five: Time to Move On? How the Right PBM Will Guide Your Implementation Process
The Fast Five: What’s all the Buzz about Biosimilars? 

Biosimilars are a hot topic in the pharmacy industry right now. Wondering what all the buzz is about?   In this Fast Five, we asked our clinical experts, Janelle Sheen and Imke Scheepers, to share the basics about biosimilars as well as some key insights on this topic.  

The Fast Five: What’s all the Buzz about Biosimilars? 
The Fast Five: Beyond Transparency

Our Vice President of Sales, Jonathan Har-Even, shares his outlook on the industry and where we need to go next. He discusses 5 ways the PBM industry can continue to improve and promote better healthcare for all, including a 5-year plan that uses lowest net cost as a foundation and builds out a platform for payors, members, and pharmacists.

The Fast Five: Beyond Transparency
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×